Angiotensin News and Research

RSS
Angiotensin is an oligopeptide in the blood that causes vasoconstriction, increased blood pressure, and release of aldosterone from the adrenal cortex. It is a powerful dipsogen. It is derived from the precursor molecule angiotensinogen, a serum globulin produced in the liver. It plays an important role in the renin-angiotensin system.
Relypsa announces positive results from Phase 2 clinical trial of RLY5016

Relypsa announces positive results from Phase 2 clinical trial of RLY5016

Enrollment in Derma Sciences DSC127 Phase 2 trial in diabetic foot ulcer healing to conclude September end

Enrollment in Derma Sciences DSC127 Phase 2 trial in diabetic foot ulcer healing to conclude September end

Scientists to present preclinical pharmacology data on TRV120027 at Heart Failure Society of America Meeting

Scientists to present preclinical pharmacology data on TRV120027 at Heart Failure Society of America Meeting

Study on kidneys may help to treat high blood pressure

Study on kidneys may help to treat high blood pressure

High vitamin D level improves survival rate in heart failure patients: Study

High vitamin D level improves survival rate in heart failure patients: Study

ANTIPAF trial reveals ARBs do not reduce number of AF episodes in paroxysmal AF patients

ANTIPAF trial reveals ARBs do not reduce number of AF episodes in paroxysmal AF patients

Telmisartan and amlodipine combination therapy helps achieve high BP control/response rates

Telmisartan and amlodipine combination therapy helps achieve high BP control/response rates

Genetic profiling to predict treatment benefits of ACE inhibitor therapy for CAD

Genetic profiling to predict treatment benefits of ACE inhibitor therapy for CAD

Selective lowering of heart rate reduces risk of death and hospitalization: Study

Selective lowering of heart rate reduces risk of death and hospitalization: Study

RLY5016 potassium binder helps to regulate hyperkalemia in heart failure patients

RLY5016 potassium binder helps to regulate hyperkalemia in heart failure patients

FDA approves Novartis' Tekamlo for treatment of high blood pressure

FDA approves Novartis' Tekamlo for treatment of high blood pressure

Study identifies four genetic variants associated with ESRD disease in Chinese diabetic patients

Study identifies four genetic variants associated with ESRD disease in Chinese diabetic patients

Researchers find how angiotensin influences immune system

Researchers find how angiotensin influences immune system

Process improvement program improves adherence to evidence-based CRT, ICD and drug therapy

Process improvement program improves adherence to evidence-based CRT, ICD and drug therapy

Study tests new performance intervention to improve heart failure patients in outpatient setting

Study tests new performance intervention to improve heart failure patients in outpatient setting

Boehringer Ingelheim announces European CHMP Positive Opinion for TWYNSTA

Boehringer Ingelheim announces European CHMP Positive Opinion for TWYNSTA

Steroid treatment can delay loss of kidney function

Steroid treatment can delay loss of kidney function

Proteinuria screening identifies risk for kidney disease progression

Proteinuria screening identifies risk for kidney disease progression

Trevena completes $35M Series B financing

Trevena completes $35M Series B financing

Researchers discover genetic links to kidney failure, diabetic kidney disease

Researchers discover genetic links to kidney failure, diabetic kidney disease

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.